Clinical and gene mutation characteristics of congenital lipoid adrenal hyperplasia and literature review

doi:10.3877/cma.j.issn.1673-5250.2020.02.010

Objective

To explore the clinical features of congenital lipoid adrenal hyperplasia (CLAH) and the characteristics of steroidogenic acute regulatory protein(StAR) gene mutations.

Methods

From July 2018 to May 2019, three children with CLAH who were treated in the children′s Hospital, Capital Institute of Pediatrics were selected into this study. The clinical data were analyzed retrospectively. Including the clinical manifestations, family genetic testing results, treatment and follow-up results were analyzed and so on. In addition, with " congenital lipoid adrenal hyperplasia" " adrenal hyperplasia" " StAR gene" " congenital adrenal hyperplasia" and " StAR" as Chinese and English key words, the literatures related to lipoid adrenal hyperplasia and steroid hormone synthesis acute regulatory protein (StAR) gene mutation were searched in PubMed database, China Medical Knowledge Infrastructure, Chinese Biomedical Literature Service System (SinoMed), China Knowledge Infrastructure and Wanfang database from database establishment to May 1, 2019. The study was approved by the ethics committee of Children′s Hospital, Capital Institute of Pediatrics (Approval No. SHERLL2020006), and the genetic testing was conducted with the informed consent of the family members of these three children.

Results

The characteristics of clinical StAR gene mutation in three children were as follows. ①Clinical manifestations: All three children had onset in infancy with clinical manifestations of adrenal insufficiency such as skin pigmentation, vomiting, and no weight gain. ②Laboratory results: Laboratory examination results of 3 children with CLAH showed low sodium, high potassium and hypoglycemia, significantly decreased cortisol levels, and significantly increased adrenocorticotropic hormone (ACTH) levels. ③ Adrenaline enhanced CT examination results: The enhanced CT findings of adrenal gland showed significant hyperplasia of bilateral adrenal glands, showing hypodense shadow (fluid-like). ④Chromosome karyotype analysis results: The karyotype of patient No.1 and patient No.3 was 46, XY, female vulva appearance. ⑤ High-throughput sequencing test results: Homozygous mutation of StAR gene was detected by high-throughput sequencing test of 3 children, and the mutation sites were located at c. 772C>T, c. 707_708delinsCTT and c. 229G>A, respectively. According to the results of literature retrieval, 23 cases of children with CLAH due to the StAR gene mutation diagnosed by genetic testing have been reported in China, which was a total of 26 cases when combined with the 3 cases included in this study. Among them, c. 772C>T (p.Q258X) accounted for 23.1%(12/52), c. 707_708delAG ins CTT (p.K236Tfs*47) accounted for 15.4% (8/52), c. 229G>A (p.Q77X) accounted for 15.4%(8/52).

Conclusions

CLAH is a rare type of congenital adrenal hyperplasia (CAH), which often onsets in infancy. It can be characterized by electrolyte disorder and male feminization, along with obstructive jaundice. The homozygous mutation site of StAR gene is located at p. Q258X, this could be a StAR hotspot mutation in Chinese population. Clinicians should pay attention to the differential diagnosis of CLAH. Genetic testing is helpful for the diagnosis of CLAH, and can provide reference for genetic consultation of CLAH.

Key words: Congenital lipoid adrenal hyperplasia, Adrenal hyperplasia, Genetic testing, StAR gene, High-throughput nucleotide sequencing, Child

表1 3例CLAH患儿实验室检查结果

患儿编号(No.)	血Na^＋(mol/L)	血K^＋(mol/L)	血Cl^－(mol/L)	雌二醇(pmol/L)	LH(IU/L)	FSH(IU/L)	睾酮(nmol/L)	血糖(mmol/L)
1	129	7.15	93	<18.35	1.98	2.31	<0.087	2.03
2	125	6.30	92	<18.35	1.67	2.25	<0.087	1.90
3	123	7.25	89	<18.35	1.02	2.52	<0.087	2.60
正常参考范围	135～145	3.50～5.50	96～106	卵泡期：45.40～854.00	卵泡期：2.40～12.60	卵泡期：3.50～12.50	<0.087	3.90～6.10
	?	?	?	排卵期：151.00～1 461.00	排卵期：14.00～95.60	排卵期：4.70～21.50	?	?
	?	?	?	黄体期：81.90～1 251.00	黄体期：1.00～11.40	黄体期：1.70～7.70	?	?
患儿编号(No.)	皮质醇(ug/dL) ^a	17-羟孕酮(ng/mL)	孕酮(nmol/L)	PRA(pg/mL)	Ang Ⅰ(ng/mL)	Ang Ⅱ(pg/mL)	醛固酮(pg/mL)
1	0.72	0.12	0.16	11	2.80	396	238
2	1.12	0.28	0.13	41	7.00	291	230
3	0.83	0.56	0.40	67	11.00	456	249
正常参考范围	6.20～19.40	0.15～1.10	卵泡期：1.18～2.84	7～19	0.07～1.51	15～97	60～174
?	?	?	排卵期：0.38～38.10	?	?	?	?
?	?	?	黄体期：5.82～75.90	?	?	?	?

表1 3例CLAH患儿实验室检查结果

患儿编号(No.)	血Na^＋(mol/L)	血K^＋(mol/L)	血Cl^－(mol/L)	雌二醇(pmol/L)	LH(IU/L)	FSH(IU/L)	睾酮(nmol/L)	血糖(mmol/L)
1	129	7.15	93	<18.35	1.98	2.31	<0.087	2.03
2	125	6.30	92	<18.35	1.67	2.25	<0.087	1.90
3	123	7.25	89	<18.35	1.02	2.52	<0.087	2.60
正常参考范围	135～145	3.50～5.50	96～106	卵泡期：45.40～854.00	卵泡期：2.40～12.60	卵泡期：3.50～12.50	<0.087	3.90～6.10
	?	?	?	排卵期：151.00～1 461.00	排卵期：14.00～95.60	排卵期：4.70～21.50	?	?
	?	?	?	黄体期：81.90～1 251.00	黄体期：1.00～11.40	黄体期：1.70～7.70	?	?
患儿编号(No.)	皮质醇(ug/dL) ^a	17-羟孕酮(ng/mL)	孕酮(nmol/L)	PRA(pg/mL)	Ang Ⅰ(ng/mL)	Ang Ⅱ(pg/mL)	醛固酮(pg/mL)
1	0.72	0.12	0.16	11	2.80	396	238
2	1.12	0.28	0.13	41	7.00	291	230
3	0.83	0.56	0.40	67	11.00	456	249
正常参考范围	6.20～19.40	0.15～1.10	卵泡期：1.18～2.84	7～19	0.07～1.51	15～97	60～174
?	?	?	排卵期：0.38～38.10	?	?	?	?
?	?	?	黄体期：5.82～75.90	?	?	?	?

图1 患儿1(女性，3个月12 d龄)肾上腺增强CT检查结果显示双侧肾上腺增生(图1A：轴位；图1B：冠状位)

图2 患儿1(女性，3个月12 d龄)及其父母StAR基因高通量测序法测序图(图2A：患儿1 StAR基因chr8：38001877存在c.772C>T纯合突变；图2B：患儿1母亲StAR基因chr8：38001877存在c.772C>T杂合突变；图2C：患儿1父亲StAR基因chr8：38001877存在c.772C>T杂合突变)

图3 患儿2(女性，5个月龄)及其母亲StAR基因高通量测序法测序图(图3A：患儿2 StAR基因chr8：38002776存在c.707_708delins CTT纯合突变；图3B：患儿2母亲StAR基因chr8：38002776存在c.707_708delins CTT杂合突变)

图4 患儿3(女性，1个月19 d龄) StAR基因高通量测序法测序图(StAR基因chr8：38005795存在c.229C>T纯合突变)

[1]	陈虹，陈瑞敏．先天性类脂性肾上腺皮质增生症研究进展[J]．中华儿科杂志，2018，56(6):470-472. DOI: 10.3760/cma.j.issn.0578-1310.2018.06.016.
[2]	Bizzarri C, Pisaneschi E, Mucciolo M, et al. Lipoid congenital adrenal hyperplasia by steroidogenic acute regulatory protein (STAR) gene mutation in an Italian infant: an uncommon cause of adrenal insufficiency [J]. Ital J Pediatr, 2017, 43(1): 57. DOI: 10.1186/s13052-017-0371-y.
[3]	韩蓓，王秀敏，顾学范. 类固醇生成急性调控蛋白作用的分子病理机制研究进展 [J]. 国外医学(遗传学分册)，2002，25(3):162-166. DOI：10.3760/cma.j.issn.1673-4386.2002.03.013
[4]	Van der Auwera GA, Carneiro MO, Hartl C, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline [J]. Curr Protoc Bioinformatics, 2013, 43: 11.10.1-11.10.33. DOI: 10.1002/0471250953.bi1110s43.
[5]	Stenson PD, Mort M, Ball EV, et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies [J]. Hum Genet, 2017, 136(6): 665-677. DOI: 10.1007/s00439-017-1779-6.
[6]	1000 Genomes Project Consortium, Auton A, Brooks LD, et al. A global reference for human genetic variation [J]. Nature, 2015, 526(7571): 68-74. DOI: 10.1038/nature15393.
[7]	Landrum MJ, Kattman BL. ClinVar at five years: delivering on the promise [J]. Hum Mutat, 2018, 39(11): 1623-1630. DOI: 10.1002/humu.23641.
[8]	Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm [J]. Nat Protoc, 2009, 4(7): 1073-1081. DOI: 10.1038/nprot.2009.86.
[9]	Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2 [J]. Curr Protoc Hum Genet, 2013, Chapter 7: Unit7.20. DOI: 10.1002/0471142905.hg0720s76.
[10]	Schwarz JM, Cooper DN, Schuelke M, et al. MutationTaster2: mutation prediction for the deep-sequencing age [J]. Nat Methods, 2014, 11(4): 361-362. DOI: 10.1038/nmeth.2890.
[11]	Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology [J]. Genet Med, 2015, 17(5): 405-424. DOI: 10.1038/gim.2015.30.
[12]	邱文娟，叶军，韩蓓，等. 先天性类脂质性肾上腺增生症分子遗传学分析[J]．中华儿科杂志，2004，42(8):585-588. DOI: 10.3760/j.issn:0578-1310.2004.08.009.
[13]	李世芹，杨慧翠，陈临琪，等. 类脂性肾上腺皮质增生症1例[J]. 实用儿科临床杂志，2010，25(5): 353-365. DOI: 1003-515X(2010)05-0353-01.
[14]	陈瑞敏，袁欣，张莹，等. 先天性类脂质性肾上腺增生症一核心家庭类固醇急性调控蛋白基因突变分析[J]. 中华内分泌代谢杂志，2014，30(11):980-984. DOI: 10.3760/cma.j.issn.1000-6699.2014.11.008.
[15]	谢婷，郑纪鹏，黄永兰，等. 先天性类脂质性肾上腺皮质增生症临床特点及StAR基因突变分析[J]. 中国当代儿科杂志，2015, 17(5): 472-476. DOI: 10.7499/j.issn.1008-8830.2015.05.012.
[16]	陈永兴，陈琼，崔岩，等. 先天性类脂质性肾上腺增生症2例临床特点及分子遗传学研究 [J]. 中华实用儿科临床杂志，2018，33(20): 1592-1594. DOI: 10.3760/cma.j.issn.2095-428X.2018.20.019.
[17]	Huang Z, Ye J, Han L, et al. Identification of five novel STAR variants in ten Chinese patients with congenital lipoid adrenal hyperplasia [J]. Steroids, 2016, 108: 85-91. DOI: 10.1016/j.steroids.2016.01.016.
[18]	Fu R, Lu L, Jiang J, et al. A case report of pedigree of a homozygous mutation of the steroidogenic acute regulatory protein causing lipoid congenital adrenal hyperplasia [J]. Medicine (Baltimore), 2017, 96(21): e6994. DOI: 10.1097/MD.0000000000006994.
[19]	王丽红，王蕾，苏艳花，等. 先天性类脂质性肾上腺增生症1例报道并文献复习 [J]. 中国医刊，2017, 52(11):92-96.
[20]	皮亚雷，张亚男，崇禾萌，等. 先天性类脂质性肾上腺增生症临床及StAR基因突变分析[J]. 河北医科大学学报，2018，39(6):684-687. DOI: 10.3969/j.issn.1008-1070.2017.11.027.
[21]	杨祖威，蒋怡然，王德芬，等. 先天性类脂质性肾上腺皮质增生症的二例家系研究 [J]. 中华内分泌代谢杂志，2018，34(4):308-311. DOI: 10.3760/cma.j.issn.1000-6699.2018.04.008.
[22]	Zhao X, Su Z, Liu X, et al. Long-term follow-up in a Chinese child with congenital lipoid adrenal hyperplasia due to a StAR gene mutation [J]. BMC Endocr Disord, 2018, 18(1): 78. DOI: 10.1186/s12902-018-0307-6.
[23]	Pomahačová R, Sykora J, Zamboryová J, et al. First case report of rare congenital adrenal insufficiency caused by mutations in the CYP11A1 gene in the Czech Republic [J]. J Pediatr Endocrinol Metab, 2016, 29(6): 749-752. DOI: 10.1515/jpem-2015-0255.
[24]	Baker BY, Lin L, Kim CJ, et al. Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia [J]. J Clin Endocrinol Metab, 2006, 91(12): 4781-4785. DOI: 10.1210/jc.2006-1565.
[25]	Rubtsov P, Karmanov M, Sverdlova P, et al. A novel homozygous mutation in CYP11A1 gene is associated with late-onset adrenal insufficiency and hypospadias in a 46，XY patient [J]. J Clin Endocrinol Metab, 2009, 94(3): 936-939. DOI: 10.1210/jc.2008-1118.
[26]	Clark BJ, Wells J, King SR, et al. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR) [J]. J Biol Chem, 1994, 269(45): 28314-28322.
[27]	Lin D, Sugawara T, Strauss JF, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis [J]. Science, 1995, 267(5205): 1828-1831.
[28]	Bose HS, Sugawara T, Strauss JF, et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia[J]. N Engl J Med, 1996, 335(25):1870-1878. DOI: 10.1056/NEJM199612193352503.
[29]	Eiden-Plach A, Nguyen HH, Schneider U, et al. Alu Sx repeat-induced homozygous deletion of the StAR gene causes lipoid congenital adrenal hyperplasia [J]. J Steroid Biochem Mol Biol, 2012, 130(1-2): 1-6. DOI: 10.1016/j.jsbmb.2011.12.016.
[30]	Bhangoo A, Gu WX, Pavlakis S, et al. Phenotypic features associated with mutations in steroidogenic acute regulatory protein[J]. J Clin Endocrinol Metab, 2005, 90(11):6303-6309. DOI: 10.1210/jc.2005-0434.

[1]	Xuan Zhang, Yutong Ma, Yuqian Miao, Yun Zhang, Shiwen Wu, Xiaochu Dang, Yingying Chen, Zhaoming Zhong, Xuejuan Wang, Miao Hu, Yanfeng Sun, Xiuzhu Ma, Faqin Lyu, Haiyan Kou. Ultrasound assessment of diaphragm function in pediatric patients with Duchenne muscular dystrophy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1068-1073.
[2]	Baofu Zhang, Jin Yu, Jingjing Ye, Jiangen Yu, Xiaohui Ma, Xiwang Liu. Echocardioimagedata diagnosis of anomalous pulmonary venous connection caused by congenital malposition of the septum primum[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1074-1080.
[3]	Dan Han, Ting Wang, Huan Xiao, Lirong Zhu, Jingyu Chen, Yi Tang. Diagnostic value of contrast enhanced ultrasound versus contrast enhanced computed tomography in benign and malignant liver lesions in children[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(09): 939-944.
[4]	Tingting Liu, Yanbing Lin, Shan Wang, Murong Chen, Zijian Tang, Dongling Dai, Bei Xia. Evaluation of metabolic dysfunction-associated fatty liver disease in children by ultrasound-guided attenuation parameter[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 787-794.
[5]	Yuhan Zhou, Huan Xiao, Chunjiang Yang, Juan Zhou, Lirong Zhu, Juan Xu, Fangting Mou. Diagnostic value of ultrasound in children with temporary hip synovitis[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 795-800.
[6]	Jiu Wang, Jun Chen, Xia Zhu, Yangjin Mima, Sheng Zhao, Xinlin Chen, Jianhua Li, Shuang Wang. Effect of implementing fetal systemic ultrasound screening in Material and Child Health Hospital of Shannan[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(07): 728-733.
[7]	Jie Mi, Chen Chen, Jialing Li, Haina Pei, Hengbo Zhang, Fei Li, Dongjie Li. Analysis of the characteristics of children's head and face trauma[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(06): 511-515.
[8]	Lichao Fan, Jinying Guo, Xin Chen. The significance of detection of wild-type RET and RET/PTC fusion gene for lymph node dissection in the central region of papillary thyroid carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 631-635.
[9]	Tao Ma, Chunwei Ye, Tao Liu, Wenxi Peng, Zhipeng Li. Comparison of laparoscopic and open disconnected pyeloplasty in the treatment of ureteropelvic junction obstruction in children[J]. Chinese Journal of Endourology(Electronic Edition), 2023, 17(06): 605-610.
[10]	Lei Wang, Shaohua Wang, Haizhen Niu, Tengfei Yin. Application of early warning intervention based on risk assessment in perioperative nursing of children with inguinal hernia[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 768-772.
[11]	Lei Lyu, Xiao Feng, Kaiming He, Kaining Zeng, Qing Yang, Haijin Lyu, Huimin Yi, Shuhong Yi, Yang Yang, Binsheng Fu. Value of revised King's score in evaluation of live transplantation timing for children with acute liver failure due to Wilson's disease and literature review[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 661-668.
[12]	Zehui Huang, Jiexian Liang, Wei Zeng. Application of dexmedetomidine combined with esketamine in painless gastroscopy in children[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 510-513.
[13]	Xiangyu Zhu, Jianmei Wang, Hui Zhang, Hongying Ye. Correlation analysis between left ventricular function parameters and liver cirrhosis using non-invasive left ventricular pressure-strain cycle[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 494-498.
[14]	Shaohong Zhuo, Xiuling Lin, Cuimei Zhou, Weilian Xiong, Xingzao Ma. Application value of CD64 index combined with serum SAA/CRP and PCT in the diagnosis of children with infectious gastrointestinal diseases[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 505-509.
[15]	Jing Li, Lingling Zhang, Wei Xing. Value of concept of interest induction before anesthesia induction in pediatric surgery and its effect on family satisfaction[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(07): 812-817.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export